Abstracts Archive - Page 147 of 1683 - ATC Abstracts

2022 American Transplant Congress
The Outcome of Clostridioides Difficile Infection in Hospitalized Intestinal Transplant Recipients
W. Amjad¹, T. Schiano², A. Malik³, M. Segovia⁴, S. Jafri⁵
¹Clinical Investigation, Harvard Medical School, Boston, MA, ²Intestinal and Liver Transplantation, Mount Sinai Medical Center, New York, NY, ³Internal Medicine, Saint Joseph's Medical Center, Stockton, CA, ⁴Small Intestine and Liver Transplant, Duke University School of Medicine, Durham, NC, ⁵Gastroenterology and Hepatology, Henry Ford Health System, Detroit, MI
*Purpose: Organ transplantation is a known risk factor of Clostridioides difficile infection. There is limited published data on the frequency and impact of CDI in…
2022 American Transplant Congress
Regional Variation in Early Effects of Acuity Circle-Based Liver Allocation
T. Ivanics¹, S. Nagai², T. Kitajima², S. Shimada², T. Shamaa², K. Collins², M. Rizzari², A. Yoshida², D. Moonka², M. Abouljoud²
¹University of Toronto - University Health Network, Toronto, ON, Canada, ²Henry Ford Hospital, Detroit, MI
*Purpose: Liver allocation in the United States was updated on February 4th, 2020, byintroducing the acuity circle (AC)-based model. This study evaluated the early effects…
2022 American Transplant Congress
Disulfide HMGB1 Reprograms Macrophages to Induce Alloimmunity via TLR4 and TLR9 Pathways Following Ischemia-Reperfusion Injury in Human Orthotopic Liver Transplantation
A. Q. Terry¹, R. A. Sosa¹, F. Kaldas², R. Busuttil³, D. Gjertson¹, J. Kupiec-Weglinski¹, E. Reed¹
¹Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA, ²University of California Los Angeles (Multi-organ), Los Angeles, CA, ³Surgery, University of California, Los Angeles, Los Angeles, CA
*Purpose: Human hepatocellular damage caused by ischemia reperfusion injury (IRI) generates the disulfide form of HMGB1 (diS HMGB1), eliciting myeloid cell activation and proinflammatory cytokine…
2022 American Transplant Congress
Dynamic Risk Prediction of Kidney Graft Failure After Deceased Donor Transplant
D. G. Hu¹, H. Thiessen Philbrook¹, S. Mohan², I. Hall³, M. Doshi⁴, K. F. Kerr⁵, C. R. Parikh¹
¹Johns Hopkins University, Baltimore, MD, ²Columbia University Medical Center, New York, NY, ³University of Utah, Salt Lake City, UT, ⁴University of Michigan, Ann Arbor, MI, ⁵University of Washington, Seattle, WA
*Purpose: Identifying kidney transplant recipients at risk of graft failure allows for early intervention in clinical care. We developed a dynamic risk prediction model based…
2022 American Transplant Congress
Identifying Predictors of Pediatric Heart Only versus Combined Heart-Liver Transplantation
K. Zhang, S. Chen, A. Syed, A. Gallo, C. Esquivel, C. Bonham, S. Hollander, M. Ma, J. Han, N. Ebel
Stanford University, Stanford, CA
*Purpose: A standardized protocol to identify which patients with Fontan failure require combined heart liver transplant (cHLT) versus isolated heart transplant (HT) has not yet…
2022 American Transplant Congress
Impact of Late and Recurrent Acute Graft Pyelonephritis on Long-Term Kidney Graft Outcomes
M. Pacaud¹, L. Colas¹, C. Kerleau², F. Le Borgne³, M. Giral², S. Brouard¹, J. Dantal²
¹CRT2I, Université de Nantes, Nantes, France, ²Service de Néphrologie et immunologie clinique, CHU de Nantes, Nantes, France, ³INSERM UMR 1246-SPHERE, Université de Nantes, Nantes, France
*Purpose: While Urinary tract infections are the most common infections in kidney transplant recipients, the impact of late acute graft pyelonephritis (AGPN) on graft outcomes…
2022 American Transplant Congress
Results of Heart Transplantation from Donation After Circulatory Death (DCD) Donors Using Thoraco-Abdominal Normothermic Regional Perfusion (TA-NRP) Compared to Donation from Donation After Brain Death (DBD) Are Similar at One Year
C. Gidea¹, L. James², D. E. Smith², J. Carillo², A. Reyentovich³, T. Saraon², S. Katz², S. Rao², R. Goldberg², B. Kadosh², M. DiVita², J. Cruz², N. Sikand², J. Ngai², G. Piper², N. Moazami²
¹New York University Langone Medical Center, New York, NY, ²NYU Langone Health, New York, NY, ³New York University Langone Health, New York, NY
*Purpose: In the U.S., interest in heart transplantation organ donation from DCD is increasing. Several different approaches are being considered. We present our institutional experience…
2022 American Transplant Congress
Robotic Living Donor Nephrectomy: The Future is Now
J. Yu, N. Vaccharajani, S. Matson, M. Scherer, J. Wellen, S. Shenoy, W. Chapman, M. Doyle, A. Khan
Surgery, Washington University School of Medicine, St. Louis, MO
*Purpose: Living donor kidney transplants represent nearly 25% of all kidney transplants performed in the United States. Over the last 10 years, an increasing emphasis…
2022 American Transplant Congress
Single Center Retrospective Study Examining the Safety of the New Potassium- Binders for Post-Operative Hyperkalemia in Kidney Transplant Recipients
S. Kapoor¹, A. Campbell², Y. Azzi¹, L. E. Liriano-Ward³, T. Shertel⁴, W. Xiao⁵, D. U. Nnani⁶, S. Farghaly¹, S. Yun⁷, E. Akalin¹, M. Ajaimy¹
¹Einstein-Montefiore Transplant Center, Bronx, NY, ²Montefiore Medical Center, Bronx, NY, ³Transplant, Montefiore Medical Center, Bronx, NY, ⁴-, -, AL, ⁵Albert Einstein College of Medicine, Folsom, CA, ⁶Pharmacy, Montefiore Medical Center, Bronx, NY, ⁷Montefiore Medical Center, New York, NY
*Purpose: We aimed to evaluate the safety and efficacy of two potassium-binders (Patiromer and Sodium Zirconium Cyclosilicate (SZC) in early post-transplant hyperkalemia treatment of kidney…
2022 American Transplant Congress
Benefit of Kidney Transplantation for Post Lung Transplantation Renal Failure: Need for Priority Allocation
S. Karhadkar¹, A. Gregor¹, K. Jonathan¹, J. Dawes¹, A. Diamond², K. Wirshup¹, A. DiCarlo¹
¹Temple University Hospital, Philadelphia, PA, ²-, Garnet Valley, PA
*Purpose: Nephrotoxicity is a major side effect of thoracic transplantation. Many patients will eventually require renal transplantation (KAL) to manage their developing ESRD. Recently, simultaneous…